Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a new build of the site; no visible content changes are indicated by this revision tag.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new version of the study page. This change reflects an update to the page version rather than any new or modified content.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small maintenance update. This update does not change the study details or visible content.SummaryDifference0.0%

- Check49 days agoChange DetectedAn updated informed consent form (Revision: v3.6.2) is now available as a PDF on the study page, replacing the older version. This update ensures current consent materials are accessible to participants.SummaryDifference0.5%

- Check63 days agoChange DetectedNew navigation and help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. The page now displays 'No longer looking for participants' to reflect recruitment status, and the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check71 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5. This reflects a minor internal update to the page rather than a change to study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.